383 related articles for article (PubMed ID: 35772465)
1. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D; Frere C; Connors JM; Khorana AA; Kakkar A; Ay C; Muñoz A; Brenner B; Prata PH; Brilhante D; Antic D; Casais P; Guillermo Esposito MC; Ikezoe T; Abutalib SA; Meillon-García LA; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2022 Jul; 23(7):e334-e347. PubMed ID: 35772465
[TBL] [Abstract][Full Text] [Related]
2. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
[TBL] [Abstract][Full Text] [Related]
3. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
[TBL] [Abstract][Full Text] [Related]
4. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
8. An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis.
Cosmi B
Expert Opin Pharmacother; 2021 Apr; 22(5):583-594. PubMed ID: 33243038
[No Abstract] [Full Text] [Related]
9. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
10. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis.
Attard LM; Gatt A; Bertoletti L; Delluc A; Riva N
Vasc Health Risk Manag; 2022; 18():793-807. PubMed ID: 36268462
[TBL] [Abstract][Full Text] [Related]
11. Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis.
Shin YE; Kumar A; Hwang M; Mackey M; Wu WK
Clin Drug Investig; 2022 Dec; 42(12):1075-1083. PubMed ID: 36315349
[TBL] [Abstract][Full Text] [Related]
12. Role of anticoagulants in therapy and prevention of recurrent venous thromboembolism in patients with cancer: a meta-analysis of randomized trials with apixaban.
Mareev VY; Mareev YV
Kardiologiia; 2022 Mar; 62(3):4-15. PubMed ID: 35414354
[TBL] [Abstract][Full Text] [Related]
13. Cancer and thrombosis: implications of published guidelines for clinical practice.
Khorana AA
Ann Oncol; 2009 Oct; 20(10):1619-30. PubMed ID: 19561038
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials.
Frere C; Farge D; Schrag D; Prata PH; Connors JM
J Hematol Oncol; 2022 May; 15(1):69. PubMed ID: 35598026
[TBL] [Abstract][Full Text] [Related]
16. The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Blann AD; Khoo CW
Vasc Health Risk Manag; 2009; 5():693-704. PubMed ID: 19707288
[TBL] [Abstract][Full Text] [Related]
17. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Bounameaux H; Brenner B; Cajfinger F; Debourdeau P; Khorana AA; Pabinger I; Solymoss S; Douketis J; Kakkar A
Lancet Oncol; 2016 Oct; 17(10):e452-e466. PubMed ID: 27733271
[TBL] [Abstract][Full Text] [Related]
18. Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer.
Soff GA
J Natl Compr Canc Netw; 2018 May; 16(5S):670-673. PubMed ID: 29784753
[TBL] [Abstract][Full Text] [Related]
19. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
Voigtlaender M; Langer F
Hamostaseologie; 2017 Oct; 37(4):241-255. PubMed ID: 28508916
[TBL] [Abstract][Full Text] [Related]
20. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
